Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
10 November 2022 - 8:30AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that Ian Mortimer,
Xenon’s President and Chief Executive Officer, along with Sherry
Aulin, Xenon’s Chief Financial Officer, will host fireside chat
presentations and participate in one-on-one meetings at the
following investor conferences:
- Guggenheim 4th Annual Immunology
and Neurology Day on Monday, November 14, 2022 with a fireside chat
presentation at 10:45 am ET
- Stifel 2022 Healthcare Conference
on Tuesday, November 15, 2022 with a fireside chat presentation at
10:20 am ET
- Jefferies London Healthcare
Conference on Thursday, November 17, 2022 with a fireside chat
presentation at 10:25 am GMT (5:25 am
ET)
Details about company presentations, webcasts,
and other events can be found on the “Investors” section of Xenon's
website at investor.xenon-pharma.com. When available, webcasts will
be posted for replay following the event. The above-listed dates
and times are subject to change.
About Xenon Pharmaceuticals
Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi
RegtsXenon Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2023 to Apr 2024